Table 1. Associations of EPB41L4A-AS2 expression with clinicpathological factors.
| Patient Features | Total No. (%) | Low EPB41L4A-AS2 No. (%) | High EPB41L4A-AS2 No. (%) | P value |
|---|---|---|---|---|
| Age (years) | 250 | 0.357 | ||
| < 50 | 160 (64.00) | 84 (52.50) | 76 (47.50) | |
| ≥ 50 | 90 (36.00) | 41 (45.56) | 49 (54.44) | |
| Tumor size | 250 | 0.026 | ||
| T1 | 65 (26.00) | 24 (36.92) | 41 (63.08) | |
| T2 | 138 (55.20) | 72 (52.17) | 66 (47.83) | |
| T3 | 47 (18.80) | 29 (61.70) | 18 (38.30) | |
| Tumor Stage | 250 | 0.016 | ||
| Stage I | 42 (16.80) | 14 (33.33) | 28 (66.67) | |
| Stage II | 168 (67.20) | 85 (50.60) | 83 (49.40) | |
| Stage III | 40 (16.00) | 26 (65.00) | 14 (35.00) | |
| Tumor Grade | 250 | 0.034 | ||
| Grade 1 | 44 (17.60) | 16 (36.36) | 28 (63.64) | |
| Grade 2 | 102 (40.80) | 48 (47.06) | 54 (52.94) | |
| Grade 3 | 104 (41.60) | 61 (58.65) | 43 (41.35) | |
| ER status | 250 | 0.013 | ||
| Positive | 156 (62.40) | 68 (43.59) | 88 (56.41) | |
| Negative | 94 (37.60) | 57 (60.64) | 37 (39.36) | |
| PR status | 250 | 0.021 | ||
| Positive | 147 (58.80) | 64 (43.54) | 83 (56.46) | |
| Negative | 103 (42.20) | 61 (59.22) | 42 (41.78) | |
| Her-2 status | 250 | 0.871 | ||
| Positive | 46 (18.40) | 24 (52.17) | 22 (47.83) | |
| Negative | 204 (72.60) | 101 (49.51) | 103 (50.49) | |
| Ki67 status | 250 | 0.591 | ||
| < 14% | 83 (33.20) | 39 (46.99) | 44 (63.01) | |
| ≥ 14% | 167 (67.80) | 86 (51.50) | 81 (48.50) |